Introduction
Page 4, line 32, "considered to have specific causes": specific cause of low back pain? I suggest you to be specific here. Page 4, line 35, "Therapists often rely on subjectively gathered": reference to support this statement? Page 5, line 7, "Whilst less predictive…": it this an accurate statement? Are variables reported in the previous paragraph predictive of LBP? My understanding is that these might be associated with LBP, but are not predictive. Page 5, lines 44 to 54: could you add some references to support statements made? Page 6, line 52: font type. Page 6, line 54: more information is required regarding the block randomization. Please refer to the CONSORT statement for information required. Page 8, line 6: will sessions be monitored by two healthcare professionals? Table 3 : I am wondering what this equipment measure. Is it force or torque (moment)? I disagree that you are assessing lumbar extension "force accuracy". At times, in your manuscript, you refer to "muscle force". As you are aware, force equals the product of mass and acceleration of an object, and you are not directly measuring "muscle force" in vivo. I would suggest re-considering the use of the term "force". Maybe, you could refer to "lumbar extensor strength accuracy" or "lumbar extensor moment accuracy" (if the equipment measures torque). On Figure 4 , you refer to torque, but in the main text you refer to force. This could be revised to enhance clarity. Apologies, but at this stage, it was unclear when the participants will have their MVIC assessed, prior to intervention. You explain it later, but I wonder whether you should present the "Biomechanical Assessment" section earlier, so that the reader understands how the MVIC was determined prior to the intervention programme. Page 11, line 52: which validity has been assessed? Construct, concurrent? I suggest you to further explain this. Page 12, line 41: again, which validity are you referring to here? I think this should be explicitly presented to the reader.
Page 12, lines 48 to 54: how will you synchronize these equipments? Page 12, lines 53 to 54, "these systems": which systems? Both WBB and Optitrak? Validated for what? What type of validity? Apologies if I missed this, but when will "Biomechanical Assessment" measurements occur (at which time points)? Auditing: what will be done if clinicians did not follow the protocol? Trial registry: -In your registry, it is clear that "biomechanical variables" are secondary outcome measures. In your submitted protocol, that is not so clear -probably the reason being the subheading you have used for "biomechanical assessment". It gives the idea that this is something else, but not one the secondary outcome measure. This could also be revised to improve clarity. -In your trial registry, you have included pain severity, IPAQ, and medication use as secondary outcome measures. You did not refer to it in your manuscript in your secondary outcome measures.
REVIEWER
Gisela Cristiane Miyamoto Universidade Cidade de Sao Paulo, Brazil REVIEW RETURNED 20-Feb-2019
GENERAL COMMENTS Dear Editor and authors,
This is a well written protocol of a randomized controlled trial that evaluates the effect of addition of lumbar neuromuscular retraining exercises in patients with chronic low back pain. Although the literature shows that there is no difference between difference types of exercise in the treatment of patients with chronic low back pain, there is still no evidence about neuromuscular retraining exercise for these patients. Thus, this protocol contains a relevant topic, it showed a good foundation in the introduction but there are some limitations in the methods, specially, in the description of interventions. Important points: Methods 1. Why were included only patients with moderate and greater disability?
2. Why were excluded patients with depression and anxiety? Most patients with chronic low back pain present a psychological disorder. This can influence in the generalizability of the study.
3. If one group receives more co-interventions, will you conduct a sensitivity analysis to know the influence of the additional intervention?
4. Will patients receive any verbal command or visual feedback during the isometric exercises in the experimental group?
5. If there is a warm-up program in the control group, how will it be performed, what is the exercises and duration? If there is no a warm-up program included this information in the manuscript.
6. What will be the intensity of the exercises program? How will the intensity of exercises program be evaluated (e.g. Borg scale)?
7. What will be the criteria for exercises progression? Will you evaluate the pain intensity before, during and after exercises?
8. In the protocol there is information that both groups will receive 30 minutes of treatment twice a week. However, the experimental group will receive combined treatment (resistance training with 30 minutes of duration and neuromuscular retraining exercise more 30 minutes). Please, could you explain it better in the protocol? There is a difference between groups related to doses of treatment if one group receives 30 minutes of treatment and another 60 minutes and this can influence the results of the study.
9. Do you expect that resistance training and neuromuscular retraining will change the psychological outcomes? Some studies that evaluated psychological outcomes did not find improvements after exercises program without psychological component.
10. Why did you not evaluate pain intensity? Pain intensity is an outcome recommended to be evaluated in low back pain studies (Core outcome domains for clinical trials in non-specific low back pain, Chiarotto et al, 2015) .
Kind regards, Gisela
VERSION 1 -AUTHOR RESPONSE

Reviewer 1 Feedback
Reviewer's comments Page Line Response In the abstract -I think you mean a sample of 94 participants (including both males and females) -otherwise it seems to be ambiguous -also an indication of how they will be recruited would be useful.
The reviewer is correct in that we will collect data from 94 participants in total (males/females combined). We have included the changes with a brief indication of how they'll be recruited (page 2, line 26-28):
'Ninety-four participants (including both males and females) with CLBP aged 18-65 who present for treatment to a Melbourne-based private physiotherapy practice will be recruited and randomised into one of two treatment groups.'
We have also expanded a more detailed description later in the body to better describe our recruitment (page 5, line 25-27):
A total of 94 participants with CLBP will be recruited from a Melbourne-based private physiotherapy clinic. New patients presenting to the clinic with CLBP will be screened by a physiotherapist for eligibility into the study.
Why the discrepancy in percentage CLBP between the world population and Australia's population. Clarify how you define "activity limiting CLBP" versus CLBP. 4
30-33
We had included Australian specific data because of the study location. However, the reviewer raises a good point as this study is being published internationally. We thank the reviewer for this comment and we have removed the sentences pertaining to Australia in the introduction.
Whilst previous research has categorised activity limiting and non-activity limiting CLBP, we agree that this differentiation is confusing and, in reality, irrelevant in the context of this paper. We have replaced it with the following paragraph which better introduces lifting biomechanics and lumbar force accuracy:
'Diminished movement coordination between the trunk and the lower limbs during lifting has been associated with the development of CLBP (Coenen et al., 2014; Nelson et al., 1995) . Moreover, people with higher CLBPrelated disability have demonstrated kinematic and kinetic mal-adaptations during lifting (Mokhtarinia et al., 2016; Sanchez-Zuriaga et al., 2011) . Indeed, a significant association (r = 0.30, p = 0.048) has been identified between trunk and movement coordination and self-reported disability (Pranata et al., 2018) . Furthermore, functional tasks such as lifting require controlled sub-maximal force production of the lumbar extensor muscles (Marras, 2008) ; there may be functional relevance in examining sub-maximal lumbar extension force accuracy. In support, a recently developed lumbar extensor force accuracy test demonstrated that it may predict up to 19% of the variance in CLBP-related disability (Pranata et al., 2017) .'
So how predictive are " the above mentioned factors". "Some of the variance" is a very loose description -can you be any clearer in your estimation?
We have decided to change the word predictive to be more accurate and state associated with instead (page 4, line 4-5). We have also removed the term 'some of the variance' and included the specific information regarding the association with lumbar muscle morphology.:
Whilst the abovementioned factors are more associated with CLBP-related disability, muscle morphology of the lumbar spine has a significant correlation with pain duration (F = 6.34, p = 0.016) (Hides et al., 2011) . No association has been established with selfreported CLBP-related disability (Hides et al., 2011; Rezazadeh et al., 2019) , however these studies participants had minimal disability, which may not be representative of a more disabled population.
Secondly, we have included information regarding the level of association for the factors of lumbar muscle force accuracy and inter-joint coordination during lifting.
A significant correlation (r = 0.30, p = 0.048) has been demonstrated between trunk and hip mean absolute relative phase angles and self-reported disability (Pranata et al., 2018) .
This recently developed assessment demonstrated that it may predict up to 19% of the variance in CLBP-related disability (Pranata et al., 2017) .
How do you know that CLBP has a symptomatic and an asymptomatic side -my own experience tells me CLBP can also be central and bilateral. You should describe this is relative to a specific group of CLBP with unilateral problems...? 5
14-16
The sentence has been changed to read (page 4, line 12-14):
Moreover, people with unilateral CLBP display significantly reduced size of the LM on the symptomatic side of the lumbar spine compared to the asymptomatic side (Hides et al., 2008) . "respond to resistance training" 5 32 This sentence now reads:
'how these muscles respond to resistance training How will you recruit participants from the community.??.or will you be recruiting participants from patients attending a clinic?. Why will they need to pay for some of their treatment (info sheet). Why will these CLBP participants present to the physiotherapy centre. I am absolutely certain there is a considerable number of people with CLBP living in the community who manage their condition themselvesand do not constantly seek the services of a physiotherapist. So in my opinion you need to be very clear in describing your recruitment strategy and procedures -and the limitations of this recruitment strategy.
6
30-32
We have changed this sentence to now read (page 5, line 25-27):
A total of 94 participants with CLBP will be recruited from a Melbourne-based private physiotherapy clinic. New patients presenting to the clinic with CLBP will be screened by a physiotherapist for eligibility into the study Potential participants will be recruited from a physiotherapy clinic, which they are attending for treatment of CLBP. Patients at this clinic typically attended on a self-funded basis twice weekly for 6 weeks. As this protocol is a 12-week program, attendance at the clinic for the additional 6 weeks is funded by our study.
We have also included a statement to reflect the limitations of this recruitment strategy. Under the heading 'recruitment and participants (page 5, line 40-43):
A physiotherapist will individually screen CLBP participants who present to the physiotherapy centre. A limitation of this recruitment strategy is that we will not be capturing people from the community who do not seek physiotherapy treatment and may manage their back pain via other professionals or self-means. you need to clarify further what you mean by "as hard as possible" 12 58 8kg is the weight of an average bag of groceries based on an international ergonomic study (Silvetti et al., 2015) ). We piloted using 10kg and 12kg in a separate study and it was considered too heavy and more likely to be provocative for participant's LBP in our study population (moderate to severe). Based on the study by Silvetti et al (2015) we felt the 8kg weight was also functionally relevant.
However, we concede that we have not adequately described our rationale. As such, we have re-worded the sentence to state:
'An 8 kg weight was selected for functional relevance as this has been defined as the average weight of a bag of groceries' confusing statement about the pillow used for US image acquisition.. should rewrite this.
13
26 We had chosen to use a pillow to reduce lumbar lordosis as some participants may find it difficulty/pain to lie in this position (as per pilot study). We have re-worded the sentence to include this:
'with a pillow placed under their pelvis to avoid excessive lumbar lordosis' "Following" baseline assessment. This has been replaced with:
'The strengthening exercises and equipment utilised in this study have been previously used in people 2 weeks post lumbar discectomy (Choi et al., 2005) . Of the 80 participants recruited, two dropped out due to increased pain with training. The risk of pain exacerbation is likely to be less, as this study does not recruit acute post-operative patients again the confusion of recruitmentparticipants or patients -directly from the community -or a "captive" population already attending a specific clinic...?
38
We have addressed this on page 5 line 25-27:
A total of 94 participants with CLBP will be recruited from a Melbourne-based private physiotherapy clinic. New patients presenting to the clinic with CLBP will be screened by a physiotherapist for eligibility into the study
We have also added (page 17, line 30-31):
Patients presenting for treatment to a Melbourne-based physiotherapy clinic will be recruited for the proposed RCT This RCT is double-blinded as both": the term double-blinded is not specific enough. This statement could be re-written and simplified as "Both the assessor and participants are blinded to their group allocation. The treating therapists are not blinded".
The statement now reads:
'Both the assessor and participants are blinded to their group allocation. The treating therapists are not blinded.' "Force accuracy": your abstract makes no reference to muscle force accuracy. So, this "strength" came as a surprise. I suggest you revising the abstract.
We have changed the abstract to state: 'strengthening exercises in combination with lumbar force accuracy training exercises'
The majority of CLBP patients don't have access to the exercise equipment and lumbar force accuracy-related software utilised in this study": do you consider this as a strength or limitation? I am assuming this is a limitation. If that is the case, the main limitation would be the ability to replicate this protocol outside the trial.
Thank you for this comment. As you've stated above regarding clarity for this section, we hope the use of subheadings will make the distinction clearer for readers. We have also changed the sentence to state: 'The trial protocol is dependent on specific equipment for replication or generalisation' "considered to have specific causes": specific cause of low back pain? I suggest you to be specific here. Whilst the abovementioned factors are more associated with CLBP-related disability, muscle morphology of the lumbar spine has a significant correlation with pain duration (F = 6.34, p = 0.016) (Hides et al., 2011) . No association has been established with selfreported CLBP-related disability (Hides et al., 2011; Rezazadeh et al., 2019) , however these studies participants had minimal disability, which may not be representative of a more disabled population.
We have also added specific information regarding the association for clarity.
Movement coordination between the trunk and the lower limbs during lifting has been associated with CLBP development (Coenen et al., 2014; Nelson et al., 1995 All the sessions will be one-to-one. We have amended this to state 'or' instead of 'and'
I am wondering what this equipment measure. Is it force or torque (moment)? I disagree that you are assessing lumbar extension "force accuracy". At times, in your manuscript, you refer to "muscle force". As you are aware, force equals the product of mass and acceleration of an object, and you are not directly measuring "muscle force" in vivo. I would suggest reconsidering the use of the term "force". Maybe, you could refer to "lumbar extensor strength accuracy" or "lumbar extensor moment accuracy" (if the equipment measures torque). Table  3 Thank you for this comment and we concede that this is confusing as per the image of the tablet displaying measures of torque. However, the load cell of the MedX machine measures force as the lever arm and the position of the seat are constant. This is converted to torque using the custom developed LabView software as per our previous paper (Pranata et al., 2017) . Therefore, the torque values only change as a function of the force on the load cell. Thus, the use of the term 'force accuracy'.
On Figure 4 , you refer to torque, but in the main text you refer to force. This could be revised to enhance clarity.
Figure 4
We have added a sentence to the strength assessment section to improve clarity for the use of torque on the image. The sentence reads:
The force exerted on the load cell is converted to torque using custom developed LabView software (Pranata et al., 2017) Apologies, but at this stage, it was unclear when the participants will have their MVIC assessed, prior to intervention. You explain it later, but I wonder whether you should present the "Biomechanical Assessment" section earlier, so that We have ordered it this way based on the SPIRIT protocol; however, we concede the point that it could be confusing for readers. Therefore, we have added a statement in this section which now reads: "Ability to replicate this protocol outside of this trial" the reader understands how the MVIC was determined prior to the intervention programme. which validity has been assessed? Construct, concurrent? I suggest you to further explain this.
11
52 We have assessed construct validity.
We have stated this for our outcome measures where validity is mentioned. For the ODI (page 10, line 17), TSK-17 (page 10, line 34), PSEQ (page 10, line 42), lumbar extension strength (page 11, line 12), lumbar extension force accuracy (page 11, line 29-30), lifting kinematics (page 12, line 4) and kinetics (page 12, line 15) again, which validity are you referring to here? I think this should be explicitly presented to the reader.
41
We are referring to construct validity.
The changes to the text are outlined for the above comment. how will you synchronize these equipments?
12
48-54
The data streams are time synchronised. Specifically, at the commencement of each lifting trial, data collection from the two devices are initiated simultaneously. 
53-54
The WBB system has been validated against force plates for measures of ground reaction force and centre of pressure. They have demonstrated good construct validity. The Optitrack system has also demonstrated good accuracy and reliability compared with the Vicon 612 system.
The sentence now reads:
The WBB have demonstrated good construct validity against the appropriate goldstandard, laboratory-grade force platform (Clark et al., 2010) . The Optitrack system has demonstrated good accuracy and reliability compared to the more expensive and widely used Vicon 612 (Carse et al., 2013) . Apologies if I missed this, but when will "Biomechanical Assessment" measurements occur (at which time points)?
All the described measurements, including the biomechanical measurements, will be taken at baseline, 6-weeks (mid-way) and 12-weeks (completion) (page 10, line 5)
We have added this into the first paragraph under outcome measures:
All primary, secondary and biomechanical outcome measures will be assessed at… Auditing: what will be done if clinicians did not follow the protocol?
This will be reported as a protocol breach. The outcomes of which will be further training for the therapist and a follow-up fidelity check for that therapist 2-weeks later.
We have included a section to the auditing section which states: 'Breaches of protocol will be reported and further training to the assessor or therapist involved will be provided. A follow-up check of the breaching party will be conducted 2 weeks later to ensure the protocol is strictly adhered to.' -In your registry, it is clear that "biomechanical variables" are secondary outcome measures. In your submitted protocol, that is not so clear -probably the reason being the subheading you have used for "biomechanical assessment". It gives the idea that this is something else, but not one the secondary outcome measure. This could also be revised to improve clarity.
We agree that this is confusing. We have changed the name to 'additional outcomes'. We have also included a statement for clarity under the heading 'additional outcomes' (page 12, line 9):
A series of additional outcomes will be collected for the purposes of answering related questions about biomechanical effects of force accuracy and strength training, and for subsequent analyses of potential mediating effects on primary and secondary outcomes. These measures will be used to determine treatment efficacy.
The ANZCTR trial registry did not allow us to distinguish between these outcomes and so they've been listed as secondary outcomes in the registry. In your trial registry, you have included pain severity, IPAQ, and medication use as secondary outcome measures. You did not refer to it in your manuscript in your secondary outcome measures.
We have amended this oversight and under the heading of 'secondary outcomes' have included information about pain intensity and the IPAQ.
The paragraph on pain intensity reads (page 10, line 22-27):
'Pain severity will be recorded using the NRS. Participants will be asked to rate their average low back pain over the past week on an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). The NRS has demonstrated good construct validity and reliability in people with CLBP [37, 38] 
The paragraph pertaining to the IPAQ (page 11, line 1-7) reads:
'The short form IPAQ will be used to evaluate participant's physical activity levels. This was to avoid any ceiling effect in disability improvements. Moreover, CLBP patients with low disability have displayed similar results to a healthy cohort on the force accuracy assessment. Hence, we wanted to include a CLBP cohort who were more likely to be challenged by this assessment and intervention.
We have included a statement in the manuscript to make this clearer for readers:
Only participants with moderate or greater disability (as per the ODI) will be included, as people with minimal CLBP-related disability have demonstrated similar results with a healthy population for the forceaccuracy assessment task (Pranata et al., 2017) . Why were excluded patients with depression and anxiety? Most patients with chronic low back pain present a psychological disorder. This can influence in the generalizability of the study.
We have misworded this criteria and had actually planned to include participants with symptoms of depression and/or anxiety. However, we will exclude individuals who are medicated for these conditions as it may alter their perception of pain severity (Salerno et al., 2002) .
We have amended the inclusion criteria to state: 'Medication managed psychological illness' If one group receives more co-interventions, will you conduct a sensitivity analysis to know the influence of the additional intervention?
We thank the reviewer for this question. Yes we will conduct a sensitivity analysis in this case.
A sensitivity analysis will be conducted in the case where one group receives more co-interventions than the other group. Will patients receive any verbal command or visual feedback during the isometric exercises in the experimental group?
The participants receive visual feedback during the isometric exercise. They have a tablet screen in front of them, which displays their real-time force measure as well as the target force. See the force accuracy tablet image (page 11, line 38) If there is a warm-up program in the control group, how will it be performed, what is the exercises and duration? If there is no a warm-up program included this information in the manuscript.
The control group will complete a warm-up exercise. I have added to the paragraph beneath the control 'group' heading (page 8, line 23-27):
'The lumbar extension strength exercise is performed before any other strength exercise. Prior to completing the lumbar strength exercise, participants will complete a warm-up consisting of two lumbar extensions performed with no weight, as well as a one-minute set of the lumbar extension exercise (table 2) at 50% of their training weight. What will be the intensity of the exercises program? How will the intensity of exercises program be evaluated (e.g. Borg scale)? What will be the criteria for exercises progression?
We have included a statement to explain the intensity of the strength exercises (page 9, line 2):
Participants will complete a MVIC on each machine they utilise throughout the study. The starting training weight will be set at 85% of the MVIC.
As the MVIC is assessed during maximum effort our training intensity is 85% of maximum intensity.
We have added to the section defining how exercises will be progressed (page 9, line 3):
Each strengthening exercise is to be completed for 90 to 120 seconds with one-to-one supervision. Participants will perform continuous repetitions with a three second concentric and eccentric phase throughout this time. Once the participant can complete the exercise for 120 seconds, the physiotherapist will increase the resistance by 5% for the next session.
Will you evaluate the pain intensity before, during and after exercises?
The therapists are evaluating pain intensity before, during and after the exercises to ensure participants do not 'flare up' their back pain. We have included a statement in the paragraph under table 2 (page 9) that states: 'The treating therapist will assess participant's pain intensity before, during and after performing each exercise using the NRS. If a participant's pain increases by a value of three out of ten, participants will be instructed to stop the exercise.' In the protocol there is information that both groups will receive 30 minutes of treatment twice a week. However, the experimental group will receive combined treatment (resistance training with 30 minutes of duration and neuromuscular retraining exercise more 30 minutes). Please, could you explain it better in the protocol? There is
We can see the confusion. Regardless of whether participants are in the control or experimental group they will be only receiving 30 minutes of exercise each session (twice per week). Whilst the experimental group is required to perform strength exercises and the force accuracy training (all up 30 minutes), the control group is doing further a difference between groups related to doses of treatment if one group receives 30 minutes of treatment and another 60 minutes and this can influence the results of the study. exercise to control for the work difference that would be there otherwise.
We have included a statement (page 7, line 29-32) to better explain the control groups work. It reads:
'Participants in the control group will complete additional time on the lumbar extension exercise, at 50% of their MVIC, that is equivalent to the time (Table 3 ) participants in the experimental group are performing the force accuracy exercise to control for work, i.e. if participants in the experimental group are completing four minutes of lumbar extensor force accuracy training then the control participants will complete four minutes lumbar extensor strength exercise performed at 50% of MVIC intensity.' Do you expect that resistance training and neuromuscular retraining will change the psychological outcomes? Some studies that evaluated psychological outcomes did not find improvements after exercises program without psychological component.
Whilst anticipate that there will be changes in psychological outcomes (likely in both groups). We also chose to examine these factors to better understand why people were /weren't demonstrating improvements in their disability. i.e. if participants disability do not improve despite their physical outcomes improving, can we explain this due to their persistently high fear avoidance beliefs or pain selfefficacy -as we know they correlate with self reported disability in this population. Why did you not evaluate pain intensity? Pain intensity is an outcome recommended to be evaluated in low back pain studies (Core outcome domains for clinical trials in nonspecific low back pain, Chiarotto et al, 2015) .
We have added a section reporting our use of the NRS to evaluate pain intensity under secondary outcome measures (page 10, line 22-27). It reads: "Pain severity will be recorded using the NRS. Participants will be asked to rate their average low back pain over the past week on an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). The NRS has demonstrated good construct validity and reliability in people with CLBP [37, 38]"
VERSION 2 -REVIEW
REVIEWER
Stephan Milosavljevic University of Saskatchewan Canada REVIEW RETURNED 19-Apr-2019
GENERAL COMMENTS
Thank you for the opportunity to further review this manuscriptthere has been a significant improvement in description, explanations and clarity. There are still some items that I consider still need to be addressed:
